The expression level of pS21GSK3α and pS9GSK3β steadily increased from normal to hyperplasia to benign tumors to carcinomas, indicating that there is an active role of inactive GSK3α/β in OTSCC progression. Here, GSK3A is linked to benign neoplasm.